Search results
Results from the WOW.Com Content Network
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
"Leucovorin is a special form of vitamin B9 that is water-soluble and does not build up in your body," he told Fox News Digital. ... "A high percentage of children with autism spectrum disorder ...
Autism spectrum disorder [a] (ASD), or simply autism, is a neurodevelopmental disorder "characterized by persistent deficits in social communication and social interaction across multiple contexts" and "restricted, repetitive patterns of behavior, interests, or activities". [11] Sensory abnormalities are also included in the diagnostic manuals ...
Autism spectrum disorder varies from child to child, which can make it challenging for clinicians to assess and know what therapies to apply. The purpose of these differentiated interventions are to intervene at the neurological level of the brain in hopes to develop appropriate responses to the different sensations from one's body and also to ...
NAAR, founded in 1994, was the first U.S. nonprofit organization dedicated to supporting research into causes, treatment, and cures for autism spectrum disorders. [18] The founders comprised a small group of parents, including two psychiatrists, a lawyer and a chemistry professor. [19]
The Journal of Autism and Developmental Disorders is a monthly peer-reviewed medical journal covering research on all aspects of autism spectrum disorders and related developmental disabilities. The journal was established in 1971 as the Journal of Autism and Childhood Schizophrenia , obtaining its current title in 1979. [ 1 ]
Research in Autism Spectrum Disorders is a peer-reviewed medical journal published monthly by Elsevier. It covers applied topics pertaining to autism spectrum disorders. Since the spring of 2023, the editor-in-chief is David Beversdorf (University of Missouri). According to the Journal Citation Reports, in 2012 the journal had an impact factor ...
Phenol sulfur transferase deficiency, in short PST deficiency, is the lack or the reduced activity of the functional enzyme phenol sulfur transferase, which is crucial in the detoxification of mainly phenolic compounds by catalysing the sulfate conjugation of the hydroxyl groups in the toxic phenolic compounds to result in more hydrophilic forms for more efficient excretion.